SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Income Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Operating Profit (Excl OI) | ₹-402 Cr | ₹-214 Cr | ₹-214 Cr |
What is the latest Operating Profit of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹-402 Cr |
| Mar2024 | ₹-214 Cr |
| Mar2023 | ₹-214 Cr |
How is Operating Profit of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-402 Cr | Negative | |
| Mar2024 | ₹-214 Cr | Negative | |
| Mar2023 | ₹-214 Cr | - | |
Compare Operating Profit of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,812.9 Cr | 29.5% | 46.5% | 8% | Stock Analytics | |
| SAGILITY | ₹19,310.5 Cr | -0.5% | -0.9% | -10.4% | Stock Analytics | |
| PRIME FOCUS | ₹18,786.7 Cr | 2.8% | -27.2% | 160.4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹18,639.4 Cr | -1% | 5.9% | -26.8% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹16,113.1 Cr | 18.9% | 2.9% | -2.5% | Stock Analytics | |
| INDEGENE | ₹12,239.0 Cr | -0.5% | 1.9% | -15.2% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 29.5% |
46.5% |
8% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses